https://www.selleckchem.com/pr....oducts/trastuzumab-d
Patients (n = 129) who dropped their SAL below threshold were more likely to be older, male, diabetic, and have more symptomatic heart failure. They also had a significantly increased risk of heart failure/death (hazard ratio [HR] 3.6, 95% confidence interval [95% CI] 2.3-5.8, P less then .0001) or death (HR 4.2, 95% CI 2.2-7.7, P less then .0001) compared to those who had sustained activity levels. Lower baseline activity level was also associated with significantly increased risk of heart failure/death and death. Conclu
Mi piace
Commento
Condividi
